Ratings by Oppenheimer (Matthew Biegler)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2021 | Nkarta Inc. | NKTX | New Coverage | Outperform (N/A) |
27.77 (30.15) |
8.57% | Details | |
| 4/6/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2021 | Aptose Biosciences | APTO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/19/2021 | Fate Therapeutics | FATE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2020 | Medicenna Therapeutics | MDNA | New Coverage | Outperform (N/A) |
3.82 (2.55) |
-33.25% | Details | |
| 11/13/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2020 | Fate Therapeutics | FATE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Marker Therapeutics | MRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Homology Medicines | FIXX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/10/2020 | Turning Point Therapeutics Inc. | TPTX | New Coverage | Outperform (N/A) |
62.77 (74.47) |
18.64% | Details | |
| 6/10/2020 | Fate Therapeutics | FATE | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/16/2020 | Homology Medicines | FIXX | Upgrade | Outperform (Perform) |
14.06 (8.64) |
-38.55% | Details | |
| 3/11/2020 | Aptose Biosciences | APTO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2020 | Marker Therapeutics | MRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/17/2020 | Aptose Biosciences | APTO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2019 | Fate Therapeutics | FATE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2019 | Marker Therapeutics | MRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2019 | Homology Medicines | FIXX | New Coverage | Perform (N/A) |
12.84 (14.06) |
9.5% | Details | |
| 7/3/2019 | Marker Therapeutics | MRKR | New Coverage | Outperform (N/A) |
8.07 (1.78) |
-77.94% | Details | |
| 1/25/2019 | Aptose Biosciences | APTO | New Coverage | Outperform (N/A) |
2.08 (2.51) |
20.67% | Details |
